Adamas News

The Rise of Decentralized Clinical Trials

The Rise of Decentralized Clinical Trials

This piece is an extract of the upcoming ADAMAS white paper “Making the Model: Solving the Data Integrity Challenge of Decentralized Clinical Trials”. It may be easy to think that Decentralized Clinical Trials (DCCTs) have emerged because of the necessity to fit...

ADAMAS Spotlight: Mason Cox

ADAMAS Spotlight: Mason Cox

At ADAMAS, our mission is to provide our clients with best-in-class expertise; our team consists of the top industry knowledge of clinical quality assurance. But we go even further beyond that, to ensure that we remain true partners to our clients, working with your...

Our Brand Evolution

Our Brand Evolution

For over two decades ADAMAS has shown an unwavering commitment to being a market leader that sets the standard for best in class service. Part of being an innovator is to be continuously looking at how we can improve. We must always be evaluating not only our services...

Your Data is Safe With ADAMAS

Your Data is Safe With ADAMAS

Did you know that ADAMAS has made significant investment in compliance with international data privacy and security requirements, in ways that may not be reflected by other smaller organisations or freelancers? For example, all of ADAMAS’s activities are governed by a...

KRIs and QTLs, Simplified

KRIs and QTLs, Simplified

It has been nearly four years since the release of ICH E6 (R2) in November 2016, however a recent poll on status of ICH E6 (R2) showed only 5% of companies as having implemented the addendum, with the top two hurdles being implementation of Risk Based Quality...

Superior Vendor Compliance with ADAMAS

Superior Vendor Compliance with ADAMAS

Did you know that ADAMAS provides an enhanced level of compliance that you may not find when selecting other contract QA organisations or small/solo contractors? ADAMAS has made a significant investment in ‘state of the art’ compliance infrastructure and processes,...

Second Wave, Second Strain

Second Wave, Second Strain

Could a second, potentially more contagious wave, of COVID-19 bring further disruption to travel and clinical trial activities? Is it possible to meet the current oversight and compliance expectations of regulatory authorities? We are all aware of the initial impact...

Do you protect your staff or your Clinical Trial?

Do you protect your staff or your Clinical Trial?

It’s a tough choice – new drugs for patients or the health and safety of your valued staff? With ADAMAS Consulting, you do not have to choose. As we keep hearing these are unprecedented times, and just recently there have been concerning articles in the scientific...

Archives